EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Challenges of Performing Controlled Trials of Diet Therapies in Gastroenterology

Alice S Day iD, Chu K Yao iD, Alexander C Ford iD, Gerald Holtmann, Emma P Halmos

JGH Open · 2026-07 · 10 (7)

DOI: 10.1002/jgh3.70439 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JGH Open, online erschienen am 27.06.2026. Verfasst von Alice S Day und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Gastroenterology and Hepatology The Queen Elizabeth Hospital Woodville South South Australia Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dietary trials methodology in the field of translational gastrointestinal research is fraught with constraints, relating to cost, practicalities of executing dietary trials, and the particulars of manipulating foods that often cannot be overcome. As such, dietary interventions may be unfairly judged as low quality. However, dietary trials are commonly poorly designed, based principally on drug trial methodology, which is often not appropriate in the setting of food, has a very different composition, and is not delivered like pharmaceuticals. This risks accurate interpretation of data and a lack of translatability to clinic. Careful attention should be given to the design of dietary trials to ensure studies remain high quality and clinically relevant. This review summarizes the key factors necessary for consideration when executing a well‐designed dietary trial for gastrointestinal conditions and examples of how they have been used and reported on. Key factors include modeling dietary composition to meet the research question, appraising pre‐exposure diets and their impact on the study, interpretation and potential use of placebo and nocebo effects, and the use of sham diets. Finally, measuring and reporting on blinding and adherence, which is essential, as for all trials methodology.

Schlagwörter

Stichwörter der Autor:innen

adherenceblindingnoceboplacebosham

Autor:innen und Institutionen

  • The Department of Gastroenterology and Hepatology The Queen Elizabeth Hospital Woodville South South Australia Australia.
  • IBD Translational Research Group Basil Hetzel Institute Woodville South South Australia Australia.
  • Department of Gastroenterology, Eastern Health Clinical School Monash University Box Hill Victoria Australia.
  • Leeds Gastroenterology Institute, St. James's University Hospital Leeds UK.
  • Leeds Institute of Medical Research at St. James's, University of Leeds Leeds UK.
  • Department of Gastroenterology and Hepatology of Princess Alexandra Hospital University of Queensland Woolloongabba Queensland Australia.

ORCID-Profile: Alice S Day, Chu K Yao, Alexander C Ford

Zitieren

APA

Day, A. S., Yao, C. K., Ford, A. C., Holtmann, G., & Halmos, E. P. (2026). The Challenges of Performing Controlled Trials of Diet Therapies in Gastroenterology. JGH Open, 10(7). https://doi.org/10.1002/jgh3.70439

Vancouver

Day AS, Yao CK, Ford AC, Holtmann G, Halmos EP. The Challenges of Performing Controlled Trials of Diet Therapies in Gastroenterology. JGH Open. 2026;10(7). doi:10.1002/jgh3.70439

BibTeX
@article{Day2026,
  author = {Day, Alice S and Yao, Chu K and Ford, Alexander C and Holtmann, Gerald and Halmos, Emma P},
  title = {The Challenges of Performing Controlled Trials of Diet Therapies in Gastroenterology},
  journal = {JGH Open},
  year = {2026},
  volume = {10},
  number = {7},
  doi = {10.1002/jgh3.70439}
}
Kostenlos starten →